GERM CELL TUMOR
Clinical trials for GERM CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GERM CELL TUMOR trials appear
Sign up with your email to follow new studies for GERM CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients out of treatment options
Disease control OngoingThis study is testing whether the drug cabozantinib can help control advanced germ cell tumors that have stopped responding to standard chemotherapy. It will involve about 50 adults whose cancer has progressed despite previous treatments. Participants will take the oral medicatio…
Matched conditions: GERM CELL TUMOR
Phase: PHASE2 • Sponsor: Jennifer King • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Engineered immune cells target Kids' brain tumors in pioneering trial
Disease control OngoingThis early-stage study is testing a new treatment for children and young adults whose brain or spinal cord tumors have come back or haven't responded to standard therapies. Doctors collect the patient's own immune cells, modify them in a lab to recognize and attack cancer cells, …
Matched conditions: GERM CELL TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with tough cancers: scientists test 'Re-Trained' immune cells
Disease control OngoingThis early-stage study is testing a new type of personalized cell therapy for children and young adults whose solid tumors have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cance…
Matched conditions: GERM CELL TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for kids with tough cancers: genetically engineered immune cells target tumors
Disease control OngoingThis early-phase study is testing the safety and feasibility of a new treatment called CAR T-cell therapy for children and young adults whose solid tumors have come back or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to be…
Matched conditions: GERM CELL TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New immune therapy tested for Tough-to-Treat testicular and ovarian cancers
Disease control OngoingThis study is testing whether two immunotherapy drugs, durvalumab and tremelimumab, can help control germ cell tumors that have returned or stopped responding to standard treatments. The trial is enrolling 30 adults whose cancers have progressed after at least one prior therapy. …
Matched conditions: GERM CELL TUMOR
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Precision proton beams target youth brain tumors, aiming to spare healthy tissue
Disease control OngoingThis study is testing whether a type of radiation called proton beam therapy can effectively treat germ cell tumors in the brain or spine while causing fewer side effects than standard radiation. It involves 45 participants aged 3 to 25 who have this type of tumor. The main goal …
Matched conditions: GERM CELL TUMOR
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Life after rare ovarian cancer: the hidden costs of survival
Knowledge-focused OngoingThis study aims to understand the long-term challenges faced by women who have survived rare ovarian cancers. Researchers are comparing 268 women who received chemotherapy plus surgery to those who had surgery alone, focusing on chronic fatigue, quality of life, and late effects …
Matched conditions: GERM CELL TUMOR
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Simple blood test could give early warning for Cancer's return
Knowledge-focused OngoingThis study is testing whether a specific substance in the blood (called miRNA 371) can help doctors predict if testicular cancer will return after initial treatment. Researchers are following 956 newly diagnosed patients for up to 3 years, collecting blood samples every few month…
Matched conditions: GERM CELL TUMOR
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC